238.90
-11.90
(-4.74%)
At close: April 10 at 9:55:01 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 20 | 19 |
| Avg. Estimate | 315.72M | 332.15M | 1.35B | 1.54B |
| Low Estimate | 308.64M | 327.9M | 1.35B | 1.51B |
| High Estimate | 321.71M | 338.05M | 1.36B | 1.57B |
| Year Ago Sales | 278.65M | 299.4M | 1.19B | 1.35B |
| Sales Growth (year/est) | 13.30% | 10.94% | 13.14% | 14.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0P8.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Initiated | B of A Securities: Buy | 3/14/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 2/19/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/19/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 2/19/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/19/2025 |
| Maintains | UBS: Buy to Buy | 2/19/2025 |